Pharma Co. Says PE Firm Owes $6.7M After Merger
180 Life Sciences Corp., a newly minted pharmaceutical company whose work includes cannabinoid research, hit a private equity firm with a breach of contract suit in New York state court on...To view the full article, register now.
Already a subscriber? Click here to view full article